NuvOx licenses stroke emulsion treatment from U. of Arkansas; Hovione files IND for topical acne med;

> NuvOx Pharma snagged an exclusive license from the University of Arkansas for a dodecafluoropentane emulsion that can reduce brain damage from stroke by over 80%. Release

> Hovione filed an investigational new drug application with the FDA for its minocycline gel, a topical delivery solution for the commonly used acne treatment. It would be the first such topical formulation approved. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.